Prenatal hyperandrogenism and lipid profile during different age stages: An experimental study

Fertility and Sterility

Volumn 99, Issue 2, 2013, Pages 551-557

  Heber, María F ^a   Ferreira, Silvana R ^a   Vélez, Leandro M ^a   Motta, Alicia B ^a,b  

^a Universidad Nacional de Río Cuarto Consejo Nacional de Investigaciones Científicas y Técnicas   (Argentina)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

lipid profile; ovarian oxidative stress; peroxisome proliferator Activated receptor gamma; Prenatal hyperandrogenization

Indexed keywords

CHOLESTEROL; GLUTATHIONE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANOVULATION; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; ESTRUS CYCLE; FAT CONTENT; FEMALE; GENE EXPRESSION; HYPERANDROGENISM; LIPID METABOLISM; LIPID PEROXIDATION; NONHUMAN; OVARY POLYCYSTIC DISEASE; OVULATION; OXIDATIVE STRESS; PHENOTYPE; PREGNANCY; PRIORITY JOURNAL; RAT; REAL TIME POLYMERASE CHAIN REACTION;

AGING; ANIMALS; FEMALE; HUMANS; HYPERANDROGENISM; LIPIDS; PPAR GAMMA; PREGNANCY; PREGNANCY COMPLICATIONS; PRENATAL EXPOSURE DELAYED EFFECTS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84873278555     PISSN: 00150282     EISSN: 15565653     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2012.10.017     Document Type: Article

References (65)

1. S. Franks Assessment and management of anovulatory infertility in polycystic ovary syndrome Endocrinol Metab Clin North Am 32 2003 639 651
2. D.A. Ehrman Polycystic ovary syndrome N Engl J Med 352 2005 1223 1236
3. S. Franks Polycystic ovary syndrome N Engl J Med 333 1995 853 861
4. L. Ibáñez, A. López-Bermejo, M. Díaz, M.V. Marcos, and F. de Zegher Early metformin therapy (age 8-12 years) in girls with precocious pubarche to reduce hirsutism, androgen excess, and oligomenorrhea in adolescence J Clin Endocrinol Metab 96 2011 262 267
5. I. Lázaro, M. Díaz, A. Cabré, L. Masana, and L. Ibañez Fatty acid-binding protein-4 plasma levels are associated to metabolic abnormalities and response to therapy in girls and young women with androgen excess Gynecol Endocrinol 27 2011 935 939
6. L. Ibáñez, A. Lopez-Bermejo, M. Diaz, M.V. Marcos, and F. de Zegher Early metformin therapy to delay menarche and augment height in girls with precocious pubarche Fertil Steril 95 2011 727 730
7. J. Bronstein, S. Tawdekar, Y. Liu, M. Pawelczak, R. David, and B. Shah Age of onset of polycystic ovarian syndrome in girls may be earlier than previously thought J Pediatr Adolesc Gynecol 24 2011 15 20
8. L. Ibañez, N. Potau, I. Francois, and F. de Zegher Precocious pubarche, hyperinsulinism and ovarian hyperandrogenism in girls: relation to reduced fetal growth J Clin Endocrinol Metab 83 1998 3558 3662
9. N. Bergvall, and S. Cnattingius Familial (shared environmental and genetic) factors and the foetal origins of cardiovascular diseases and type 2 diabetes: a review of the literature J Intern Med 264 2008 205 223
10. S. Franks Do animal models of polycystic ovary syndrome help to understand its pathogenesis and management? Yes, but their limitations should be recognized Endocrinology 150 2009 3983 3985
11. D.H. Abbott, D.K. Barnett, C.M. Bruns, and D.A. Dumesic Androgen excess fetal programming of female reproduction: a developmental aetiology for polycystic ovary syndrome? Hum Reprod Update 11 2005 357 374
12. T. Sir-Petermann, E. Codner, M. Maliqueo, B. Echiburú, C. Hitschfeld, and N. Crisosto Increased anti-Mullerian hormone serum concentrations in prepubertal daughters of women with polycystic ovary syndrome J Clin Endocrinol Metab 91 2006 3105 3109
13. D. Abbott, C.R. Bruns, D.K. Barnett, A. Dunaif, T.L. Goodfriend, and D.A. Dumesic Experimentally induced gestational androgen excess disrupts glucoregulation in rhesus monkey dams and their female offspring Am J Physiol Endocrinol Metab 299 2010 E741 E751
14. L. Ibañez, N. Potau, P. Chacon, C. Pascual, and A. Carrascosa Hyperinsulinemia, dyslipemia and cardiovascular risk in girls with a history of premature pubarche Diabetologia 41 1998 1057 1063
15. L. Ibañez, F. de Zegher, and N. Potau Anovulation after precocious pubarche: early markers and time course in adolescence J Clin Endocrinol Metab 84 1999 2691 2695
16. L. Ibañez, C. Castell, R. Tresserras, and N. Potau Increased prevalence of type 2 diabetes mellitus and impaired glucose tolerance in first degree relatives of girls with a history of precocious pubarche Clin Endocrinol 51 1999 395 401
17. T. Sir-Petermann, C. Hitchsfeld, M. Maliqueo, E. Codner, B. Echiburu, and R. Gazitúa Birth weight in offspring of mothers with polycystic ovary syndrome Hum Reprod 20 2005 2122 2126
18. S. Bjercke, P.O. Dale, T. Tanbo, R. Storeng, G. Ertzeid, and T. Abyholm Impact of insulin resistance on pregnancy complications and outcome in women with polycystic ovary syndrome Gynecol Obstet Invest 54 2002 94 99
19. L. Haakova, D. Cibula, K. Rezabek, M. Hill, M. Fanta, and J. Zivny Pregnancy outcome in women with PCOS and in controls matched by age and weight Hum Reprod 18 2003 1438 1441
20. M. Mikola, V. Hiilesmaa, M. Halttunen, L. Suhonen, and A. Tiitinen Obstetric outcome in women with polycystic ovarian syndrome Hum Reprod 16 2001 226 229
21. H. Anderson, N. Fogel, S.K. Grebe, R.J. Singh, R.L. Taylor, and A. Dunaif Infants of women with polycystic ovary syndrome have lower cord blood androstenedione and estradiol levels J Clin Endocrinol Metab 95 2010 2180 2186
22. A.B. Motta Report of the international symposium. Polycystic ovary syndrome: first Latin-American consensus Int J Clin Pract 64 2010 544 557
23. R.S. Legro, R.L. Roller, W.C. Dodson, C.M. Stetter, A.R. Kunselman, and A. Dunaif Association of birthweight and gestational age with reproductive and metabolic phenotypes in women with polycystic ovarian syndrome an their first-degree relatives J Clin Endocrinol Metab 95 2010 789 799
24. S. Amalfi, L. Velez, F. Heber, S. Vighi, A. Vega-Orozco, and O. Pignataro Prenatal hyperandrogenization induces metabolic and endocrine alterations which depend on the levels of testosterone exposure PloS One 7 2012 e37658
25. D.J. Barker, C. Osmond, J. Golding, D. Kuh, and M.E. Wadsworth Growth in utero, blood pressure in childhood and adult life, and mortality from cardiovascular disease BMJ 298 1989 564 567
26. D.J.P. Barker, A.R. Ball, C. Osmond, and S.J. Simons Fetal and placental size and risk of hypertension in adult life BMJ 301 1990 259 262
27. D.J.P. Barker, C.N. Hales, C.H.D. Fall, C. Osmond, K. Phipps, and P.M. Clark Type 2 (non-insulin dependent) diabetes mellitus, hypertension and hyperlipidemia (syndrome X): relation to reduced fetal growth Diabetologia 36 1993 62 67
28. C.N. Hales, D.J. Barker, P.M. Clark, C.N. Hales, Y. Stirling, and T.W. Meade Fetal and infant growth and impaired glucose tolerance at age 64 BMJ 303 1991 1019 1022
29. T. Sabuncu, H. Vural, M. Harma, and M. Harma Oxidative stress in polycystic ovary syndrome and its contribution to the risk of cardiovascular disease Clin Biochem 34 2001 407 413
30. R. Fernandez-Fernandez, A.C. Martín, V.M. Navarro, J.M. Castellano, C. Dieguez, and E. Aguilar Novel signs for the integration of energy balance and reproduction Mol Cell Endocrinol 254-5 2006 127 132
31. I. Issemann, and S. Green Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators Nature 347 1990 645 660
32. C.M. Komar Peroxisome proliferator-Activated receptors (PPARs) and ovarian function- implications for regulating steroidogenesis, differentiation, and tissue remodeling Reprod Biol Endocrinol 3 2005 41 55
33. Z. Huang, X. Zhou, A.C. Nicholson, A.M. Gotto Jr., D.P. Hajjar, and J. Han Activation of peroxisome proliferator-Activated receptor-Alpha in mice induces expression of the hepatic low-density lipoprotein receptor Br J Pharmacol 155 2008 596 605
34. Y. Cui, K. Miyoshi, E. Claudio, U.K. Siebenlist, F.J. Gonzalez, and J. Flaws Loss of the peroxisome proliferation-Activated receptor gamma (PPARgamma) does not affect mammary development and propensity for tumor formation but leads to reduced fertility J Biol Chem 277 2002 17830 17835
35. M. Faut, E.M. Elia, F. Parborell, N.C. Cugnata, M. Tesone, and A.B. Motta Peroxisome proliferator-Activated receptor gamma and early folliculogenesis during an acute hyperandrogenism condition Fertil Steril 95 2011 333 337
36. M. Demissie, M. Lazic, E.M. Foecking, F. Aird, and A. Dunaif Transient prenatal androgen exposure produces metabolic síndrome in adult female rats Am J Physiol Endocrinol Metab 295 2008 E262 E268
37. I.L. Ward, O.B. Ward, J.D. Affuso, W.D. Long 3rd, J.A. French, and S.E. Hendricks Fetal testosterone surge: specific modulations induced in male rats by maternal stress and/or alcohol consumption Horm Behav 43 2003 531 539
38. W.T. Friedewald, R.I. Levy, and D.S. Fredrickson Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge Clin Chem 18 1972 499 502
39. A. Motta, A. Estevez, A. Franchi, S. Perez-Martinez, M. Farina, and M.L. Ribeiro Regulation of lipid peroxidation by nitric oxide and PGF2alpha during luteal regression in rats Reproduction 121 2001 631 637
40. E. Elia, V. Sander, C. Luchetti, M.E. Solano, G. Di Girolamo, and D. Gonzalez The mechanisms involved in the action of metformin in regulating ovarian function in hyperandrogenized mice Mol Hum Reprod 12 2006 475 481
41. T.K. Woodruff, R.J. Lyon, S.E. Hansen, G.C. Rice, and J.P. Mather Inhibin and activin locally regulate rat ovarian folliculogenesis Endocrinology 127 1990 3196 3205
42. V. Padmanabhan, A. Veiga-Lopez, D.H. Abbott, S.E. Recabarren, and C. Herkimer Developmental programming: impact of prenatal testosterone excess and postnatal weight gain on insulin sensitivity index and transfer of traits to offspring of overweight females Endocrinology 151 2010 595 605
43. V. Nisenblat, and R.J. Norman Androgens and polycystic ovary syndrome Curr Opin Endocrinol Diabetes Obes 16 2009 224 231
44. D.H. Abbott, D.K. Barnett, J.E. Levine, V. Padmanabhan, D.A. Dumesic, and S. Jacoris Endocrine antecedents of polycystic ovary syndrome in fetal and infant prenatally androgenized female rhesus monkeys Biol Reprod 79 2008 154 163
45. S.E. Recabarren, V. Padmanabhan, E. Codner, A. Lobos, C. Durán, and M. Vidal Postnatal developmental consequences of altered insulin sensitivity in female sheep treated prenatally with testosterone Am J Physiol Endocrinol Metab 289 2005 E801 E806
46. M. Rizzo, R.A. Longo, E. Guastella, G.B. Rini, and E. Carmina Assessing cardiovascular risk in Mediterranean women with polycystic ovary syndrome J Endocrinol Invest 34 2011 422 426
47. M. Maliqueo, J.E. Galgani, F. Pérez-Bravo, B. Echiburú, A.L. de Guevara, and N. Crisosto Relationship of serum adipocyte-derived proteins with insulin sensitivity and reproductive features in pre-pubertal and pubertal daughters of polycystic ovary syndrome women Eur J Obstet Gynecol Reprod Biol 161 2012 56 61
48. E. Diamanti-Kandarakis, P.M. Spritzer, T. Sir-Petermann, and A.B. Motta Insulin resistance and polycystic ovary syndrome through life Curr Pharm Des 2012 Jul 24 [Epub ahead of print.]
49. H. Kimm, S.W. Lee, H.S. Lee, K.W. Shim, C.Y. Cho, J.E. Yun, and S.H. Jee Associations between lipid measures and metabolic syndrome, insulin resistance and adiponectin. Usefulness of lipid rations is Korean men and women Circ J 74 2010 931 937
50. A.S. Wierzbicki, R.E. Clarke, A. Viljoen, and D.P. Mikhailidis Triglycerides: a case for treatment? Curr Opin Cardiol 398 2012 398 404
51. E. Diamanti-Kandarakis, A. Piouka, S. Livadas, C. Piperi, I. Katsikis, and A. Papavassiliou Anti-mullerian hormone is associated with advanced glycosylated end products in lean women with polycystic ovary syndrome Eur J Endocrinol 160 2009 847 853
52. J. Kwintkiewicz, R.Z. Spaczynski, N. Foyouzi, T. Pehlivan, and A.J. Duleba Insulin and oxidative stress modulate proliferation of rat ovarian theca-interstitial cells through diverse signal transduction pathways Biol Reprod 74 2006 1034 1040
53. C. Charitidou, D. Farmakiotis, V. Zournatzi, I. Pidonia, T. Pegiou, and N. Karamanis The administration of estrogens, combined with anti-Androgens, has beneficial effects on the hormonal features and asymmetric dimethylarginine levels, in women with the polycystic ovary syndrome Atherosclerosis 196 2008 958 965
54. J.W. Baynes Role of oxidative stress in development of complications in diabetes Diabetes 40 1991 405 412
55. N.K. Kuscu, and A. Var Oxidative stress but not endothelial dysfunction exists in non-obese, young group of patients with polycystic ovary syndrome Acta Obstet Gynecol Scand 88 2009 612 617
56. V. Fenkci, S. Fenkci, M. Yilmazer, and M. Serteser Decreased total antioxidant status and increased oxidative stress in women with polycystic ovary syndrome may contribute to the risk of cardiovascular disease Fertil Steril 80 2003 123 127
57. M.A. Martinez-Garcia, M. Luque-Ramirez, J.L. San Millán, and H.F. Escobar-Morreale Body iron stores and glucose intolerante in premonopausal women: role of hyperandrogenism, insulina resistance, and genomic variants related to inflammation, oxidative stress, andi ron metabolismo Diab Care 32 2009 1525 1530
58. E. Cakir, M. Ozbek, E. Ozkaya, N. Colak, E. Cakal, and M. Sayki Oxidative stress markers are not valuable markers in lean and early age of polycystic ovary syndrome patients J Endocrinol Invest 34 2011 178 182
59. J.K. Rodrigues, L.A. Dib, R.A. Ferriani, A.A. Jordão Junior, and P.A. Navarro Serum markers of oxidative stress and assisted reproduction procedures results in infertile patients with polycystic ovary syndrome and controls Rev Bras Ginecol Obstet 32 2010 118 125
60. N. Sugino, S. Takiguchi, S. Kashida, H. Takayama, Y. Yamagata, and Y. Nakamura Suppression of intracellular superoxide dismutase activity by antisense oligonucleotides causes inhibition of luteal cells Biol Reprod 61 1999 1133 1138
61. E. González, J. Roselló-Catafau, A. Jawerbaum, D. Sinner, C. Pustovrh, and J. Vela Pancreatic nitric oxide and oxygen free radicals in the early stages of streptozotocin-induced diabetes mellitus in the rat Braz J Med Biol Res 33 2000 1335 1342
62. M.C. Pustovrh, A. Jawerbaum, E. Capobianco, V. White, N. Martínez, and J.J. López-Costa Oxidative stress promotes the increase of matrix metalloproteinases-2 and -9 activities in the feto-placental unit of diabetic rats Free Radic Res 39 2005 1285 1293
63. V.A. Sander, J. Piehl, G.B. Facorro, E. Rubín de Celis, and A.B. Motta Regulation of functional and regressing stages of corpus luteum development in mice. Role of reactive oxygen species Reprod Fertil Dev 20 2008 760 769
64. E.M. Elia, D. Belgorosky, M. Faut, S. Vighi, C. Pustovrh, and L. Devoto The effects of metformin on uterine tissue of hyperandrogenized BALB/c mice Mol Hum Reprod 15 2009 421 432
65. V.A. Sander, G.B. Facorro, L. Piehl, E. Rubín de Celis, and A.B. Motta Effect of dehydroepiandrosterone and metformin on corpus luteum in mice Reproduction 138 2009 571 579